Gain-of-function factor H–related 5 protein impairs glomerular complement regulation resulting in kidney damage
Open Access
- 22 March 2021
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (13)
Abstract
Genetic variation within the factor H–related (FHR) genes is associated with the complement-mediated kidney disease, C3 glomerulopathy (C3G). There is no definitive treatment for C3G, and a significant proportion of patients develop end-stage renal disease. The prototypical example is CFHR5 nephropathy, through which an internal duplication within a single CFHR5 gene generates a mutant FHR5 protein (FHR5mut) that leads to accumulation of complement C3 within glomeruli. To elucidate how abnormal FHR proteins cause C3G, we modeled CFHR5 nephropathy in mice. Animals lacking the murine factor H (FH) and FHR proteins, but coexpressing human FH and FHR5mut (hFH-FHR5mut), developed glomerular C3 deposition, whereas mice coexpressing human FH with the normal FHR5 protein (hFH-FHR5) did not. Like in patients, the FHR5mut had a dominant gain-of-function effect, and when administered in hFH-FHR5 mice, it triggered C3 deposition. Importantly, adeno-associated virus vector-delivered homodimeric mini-FH, a molecule with superior surface C3 binding compared to FH, reduced glomerular C3 deposition in the presence of the FHR5mut. Our data demonstrate that FHR5mut causes C3G by disrupting the homeostatic regulation of complement within the kidney and is directly pathogenic in C3G. These results support the use of FH-derived molecules with enhanced C3 binding for treating C3G associated with abnormal FHR proteins. They also suggest that targeting FHR5 represents a way to treat complement-mediated kidney injury. Significance The complement system is integral to innate immunity and host defense. However, inappropriate activation causes host tissue damage and disease. In health, this is prevented by a complex protein network that includes the factor H proteins. Understanding control of complement is critical to treat complement-mediated disease. We demonstrate that a gain-of-function mutant factor H–related 5 protein (FHR5) results in glomerular damage. The mutant interfered with complement regulation within the kidney, resulting in complement accumulation within glomeruli and kidney damage. Administration of a complement regulator with enhanced surface regulatory activity reduced mutant-associated glomerular complement. FHR5 can disrupt the homeostatic regulation of complement within the kidney, and targeting FHR5 represents a way to treat some types of complement-mediated kidney injury.Keywords
This publication has 44 references indexed in Scilit:
- Dimerization of complement factor H-related proteins modulates complement activation in vivoProceedings of the National Academy of Sciences, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Factor H-related Protein 4 Activates Complement by Serving as a Platform for the Assembly of Alternative Pathway C3 Convertase via Its Interaction with C3b ProteinJournal of Biological Chemistry, 2012
- Genome-wide association study identifies susceptibility loci for IgA nephropathyNature Genetics, 2011
- Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritisThe Lancet, 2010
- Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient miceKidney International, 2010
- Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phaseMolecular Immunology, 2009
- Translational Mini-Review Series on Complement Factor H: Renal diseases associated with complement factor H: novel insights from humans and animalsClinical and Experimental Immunology, 2008
- Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domainsJournal of Experimental Medicine, 2007
- Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient miceProceedings of the National Academy of Sciences, 2006